Search
for
Sort by
Research 571–600 of 1000+
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
- Medical complications of anorexia nervosa and bulimia nervosa
- Treatment of invasive aspergillosis with itraconazole
- The Rotterdam Study: 2016 objectives and design update
- Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
- Leucine-Rich Repeat-Containing G-Protein-Coupled Receptors as Markers of Adult Stem Cells
- Anatomy and Physiology of the Skin
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Anthracycline analogs The past, present, and future
- Efficacy and safety of omeprazole for severe gastroesophageal reflux in children
- The pharmacology of methotrexate
- Alopecia areata
- Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice.
- Lupus erythematosus: systemic and cutaneous manifestations
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Protoporphyrin IX: the Good, the Bad, and the Ugly
- A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
- Macrophages Regulate Schwann Cell Maturation after Nerve Injury
- Hair Loss in Women
- Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy
- Oxidative stress in ageing of hair
- Folliculitis decalvans
- The histopathologic spectrum of psoriasis
- Interferon in the treatment of cutaneous T-cell lymphoma
- Aging of hair
- Nutrition and Hair
- Reversal of Baldness in Patient Receiving Minoxidil for Hypertension
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors